32.4% decrease in cases from the week ending 9 January 2022 compared to the preceding week.
No booster policy for South Sudan in place. Priority is to increase COVID-19 vaccination coverage of population over 18 up to at least 40%.
Single dose Johnson & Johnson is preferred vaccine for South Sudan, with Astra Zeneca the second option.
No other vaccine types are considered for the time being.